RESEARCH-USE BIOSIMILAR ANTIBODY

Suptavumab

Monoclonal antibody · IgG1

RSV gpFIgG1RUO

Suptavumab (REGN2222) is a human monoclonal antibody. Suptavumab can bind and block a conserved epitope on RSV A and B subtypes. Suptavumab can be used for the research of RSV infection.

TARGETRSV gpF
YMonoclonal antibody
CATALOGSC-BS-147
CATALOG NUMBERSC-BS-147
MOLECULAR WEIGHTApprox. 145.8 kDa
PRODUCT FORMATMonoclonal antibody

A research-use configuration for comparative antibody studies

Suptavumab (REGN2222) is a human monoclonal antibody. Suptavumab can bind and block a conserved epitope on RSV A and B subtypes. Suptavumab can be used for the research of RSV infection.

Suptavumab is a recombinant research-use antibody directed against RSV gpF.

START A CONVERSATION

Tell us about your research goals.

For quotes, sample requests or technical support, start with your target and experimental context.

Contact StellaCyte
Suptavumab | StellaCyte